SkyVaricella

NBP608 · SK Bioscience Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SkyVaricella, covering 2023-07-06 to 2026-02-17. Get the full timeline:

Most recent: Clinical Trial Update: SkyVaricella® (NBP608) Vaccine With Lower Potencies in Healthy Children Aged 12 Months to 12 Years [Phase 3]